SCHEMBL8336506

SCHEMBL8336506

CCCCC(C)N(C(=O)C(C)c1ccc(C)c(N=S(=O)=O)c1)C(=S)NC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8333029 0.97 ALDH1A1 (0.31) —
SCHEMBL8340674 0.96 ALDH1A1 (0.33) —
SCHEMBL8336132 0.94 — —
SCHEMBL8340570 0.91 LMNA (0.30) —
SCHEMBL8339418 0.90 BCHE (0.32) —
SCHEMBL8338614 0.89 SMN1; SMN2 (0.35) —
SCHEMBL8340832 0.86 BCHE (0.30) —
SCHEMBL8333965 0.86 BCHE (0.32) —
SCHEMBL8338441 0.86 SMN1; SMN2 (0.34) —
SCHEMBL8339742 0.86 BCHE (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977177-A Substituted benzenesulfonylureas and-thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1999-11-02 — — US disclosed
US-5880155-A TREATMENT OF CARDIOVASCULAR DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1999-03-09 — — US disclosed
Send feedback